Skip to search formSkip to main contentSkip to account menu

Combined hyperlipidemia

Known as: Combined hyperlipidaemia, Multiple-type hyperlipoproteinemia 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Aim. To study simvastatin effects on lipid metabolism in elderly patients with Type 2 diabetes mellitus (DM-2) and isolated… 
2014
2014
OBJECTIVE To explore serum redox status differences among different types of dyslipidemia patients. METHOD One hundred and… 
Review
2007
Review
2007
This review considers the treatment for combined hyperlipidaemia (CH) with a combination formulation of three drugs: a statin… 
2004
2004
Background APOE polymorphism is believed to confer susceptibility to coronary heart disease (CHD) and Alzheimer’s disease. It is… 
2002
2002
Combined hyperlipidemia (CHL) is a common disorder of lipid metabolism that leads to an increased risk of cardiovascular disease… 
1998
1998
Hypertriglyceridaemia is a common metabolic disorder frequently found in patients with coronary heart disease. Numerous studies… 
1995
1995
This study demonstrates that peripheral apolipoprotein(a) [apo(a)] levels are higher in patients with polygenic… 
1991
1991
UNLABELLED Dietary recommendations for the treatment of hypercholesterolemia (HC) emphasize stepwise reductions in fat intake… 
1987
1987
Bezafibrate (BZ) is an efficient lipid-lowering drug that is effective in several types of hyperlipidemia (1). BZ reduces high…